Antidepressants included in the study.

<p>Table shows the generic names and their corresponding ATC codes for antidepressants included in the present study. SSRI: Selective Serotonine Reuptake Inhibitor; TCA: Tri Cyclic Antidepressant (Non-selective Monoamine Reuptake Inhibitor).</p

Basic characteristics for women exposed to an antidepressant during pregnancy.

<p>Table shows the number (n) of pregnant women within each subcategory. Some women were exposed to several antidepressants during pregnancy. Number in parenthesis denotes percentage of pregnant women within each exposure. Information on BMI was only available for women giving birth after 1 January 2004. Chi-square tests were used to assess the overall p value for the group comparison between unexposed and women exposed to “any AD”.BMI, body mass index; SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants; AD, antidepressant.</p

Pre-pregnancy treatment-naïve women exposed to an antidepressant.

<p>Number of pre-pregnancy treatment-naive women exposed to an antidepressant during and after pregnancy. Number in parenthesis is the percentage of ‘any antidepressant’. Sum of percentages adds up to more than 100% due to some pregnancies being exposed to more than one antidepressant in the given period. SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants; AD, antidepressant.</p

Number of women exposed to an antidepressant during pregnancy.

<p>Number in parenthesis is the percentage of ‘any antidepressant’. Sum of percentages adds up to more than 100% due to some pregnancies being exposed to more than one antidepressant in the given period. SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants; AD, antidepressant.</p

Percentage of pregnant women in treatment with an antidepressant for each day from 180 days before conception to 630 days after conception (approximately 1 year after mean time of delivery).

<p>The figure is divided into three areas of different color indicating the period of treatment start; before (dark blue), during (blue) or after pregnancy (light blue).</p

Point prevalence of pregnant women in treatment with an antidepressant based on estimated treatment periods.

<p>SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressants; AD, antidepressant.</p

Basic characteristics.

<p>Basic characteristics.</p

The hazard ratio of having a miscarriage when redeeming a prescription of a drug in the first trimester of pregnancy.

<p>All hazards are adjusted for age, parity, educational level, and income. *Proton pump inhibitors.</p

Exposure to clarithromycin in the first trimester.

<p>CI95%, 95% confidence intervals.</p

Sensitivity analyses. Adjusted hazard ratios of having a miscarriage when redeeming a prescription in the first trimester compared to unexposed.

<p>Sensitivity analyses. Adjusted hazard ratios of having a miscarriage when redeeming a prescription in the first trimester compared to unexposed.</p